BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 11459832)

  • 1. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.
    Lin WC; Lin FT; Nevins JR
    Genes Dev; 2001 Jul; 15(14):1833-44. PubMed ID: 11459832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM is a target for positive regulation by E2F-1.
    Berkovich E; Ginsberg D
    Oncogene; 2003 Jan; 22(2):161-7. PubMed ID: 12527885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity in the activation and control of transcription factor E2F-dependent apoptosis.
    Hallstrom TC; Nevins JR
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10848-53. PubMed ID: 12954980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage.
    Ianari A; Gallo R; Palma M; Alesse E; Gulino A
    J Biol Chem; 2004 Jul; 279(29):30830-5. PubMed ID: 15123636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 transcription is induced by genotoxic stress through ATM/ATR activation.
    Carcagno AL; Ogara MF; Sonzogni SV; Marazita MC; Sirkin PF; Ceruti JM; Cánepa ET
    IUBMB Life; 2009 May; 61(5):537-43. PubMed ID: 19391166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.
    Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE
    Nat Cell Biol; 2003 Jul; 5(7):655-60. PubMed ID: 12833065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.
    Rogoff HA; Pickering MT; Frame FM; Debatis ME; Sanchez Y; Jones S; Kowalik TF
    Mol Cell Biol; 2004 Apr; 24(7):2968-77. PubMed ID: 15024084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.
    Yoshida M; Shiojima I; Ikeda H; Komuro I
    J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway.
    Pamment J; Ramsay E; Kelleher M; Dornan D; Ball KL
    Oncogene; 2002 Nov; 21(51):7776-85. PubMed ID: 12420214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
    Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
    Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of E2F1 by BRCT domain-containing protein TopBP1.
    Liu K; Lin FT; Ruppert JM; Lin WC
    Mol Cell Biol; 2003 May; 23(9):3287-304. PubMed ID: 12697828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis.
    Wang B; Liu K; Lin FT; Lin WC
    J Biol Chem; 2004 Dec; 279(52):54140-52. PubMed ID: 15494392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53.
    Wang J; Pabla N; Wang CY; Wang W; Schoenlein PV; Dong Z
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1300-7. PubMed ID: 16849690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.